Daiichi Sankyo signs data deal for anti-cancer therapies
Daiichi Sankyo will receive exclusive access to DarwinHealth’s cancer database to identify potential targets for anti-cancer drug development.
Archives for April 6, 2018
Settled lawsuit paves way for Humira biosimilar in EU from October
The first Humira (adalimumab) biosimilar could be available in Europe by October after Samsung Bioepis settled a lawsuit with AbbVie.